293 related articles for article (PubMed ID: 24571647)
1. Plasma level of LDL-cholesterol at diagnosis is a predictor factor of breast tumor progression.
Rodrigues Dos Santos C; Fonseca I; Dias S; Mendes de Almeida JC
BMC Cancer; 2014 Feb; 14():132. PubMed ID: 24571647
[TBL] [Abstract][Full Text] [Related]
2. Could Anthropometric and Lipid Parameters Reflect Susceptibility to Breast Cancer? Comparison of Newly Diagnosed Breast Cancer and Apparently Healthy Women.
Akalanka HMK; Ekanayake S; Samarasinghe K
Asian Pac J Cancer Prev; 2018 Sep; 19(9):2475-2480. PubMed ID: 30255702
[TBL] [Abstract][Full Text] [Related]
3. Plasma apolipoprotein A1 levels at diagnosis are independent prognostic factors in invasive ductal breast cancer.
Lin X; Hong S; Huang J; Chen Y; Chen Y; Wu Z
Discov Med; 2017 Apr; 23(127):247-258. PubMed ID: 28595037
[TBL] [Abstract][Full Text] [Related]
4. [Association of serum lipid profile with distant metastasis in breast cancer patients].
Liu YL; Qian HX; Qin L; Zhou XJ; Zhang B; Chen X
Zhonghua Zhong Liu Za Zhi; 2012 Feb; 34(2):129-31. PubMed ID: 22780931
[TBL] [Abstract][Full Text] [Related]
5. Serum lipids and outcome of early-stage breast cancer: results of a prospective cohort study.
Bahl M; Ennis M; Tannock IF; Hux JE; Pritchard KI; Koo J; Goodwin PJ
Breast Cancer Res Treat; 2005 Nov; 94(2):135-44. PubMed ID: 16261412
[TBL] [Abstract][Full Text] [Related]
6. [A case-control study on the association between serum lipid level and the risk of breast cancer].
Wei LJ; Zhang C; Zhang H; Wei X; Li SX; Liu JT; Ren XB
Zhonghua Yu Fang Yi Xue Za Zhi; 2016 Dec; 50(12):1091-1095. PubMed ID: 28057114
[No Abstract] [Full Text] [Related]
7. Pretreatment Insulin Levels as a Prognostic Factor for Breast Cancer Progression.
Ferroni P; Riondino S; Laudisi A; Portarena I; Formica V; Alessandroni J; D'Alessandro R; Orlandi A; Costarelli L; Cavaliere F; Guadagni F; Roselli M
Oncologist; 2016 Sep; 21(9):1041-9. PubMed ID: 27388232
[TBL] [Abstract][Full Text] [Related]
8. The effect of preoperative serum triglycerides and high-density lipoprotein-cholesterol levels on the prognosis of breast cancer.
Li X; Tang H; Wang J; Xie X; Liu P; Kong Y; Ye F; Shuang Z; Xie Z; Xie X
Breast; 2017 Apr; 32():1-6. PubMed ID: 27939967
[TBL] [Abstract][Full Text] [Related]
9. Status of lipid and lipoprotein in female breast cancer patients at initial diagnosis and during chemotherapy.
Li X; Liu ZL; Wu YT; Wu H; Dai W; Arshad B; Xu Z; Li H; Wu KN; Kong LQ
Lipids Health Dis; 2018 Apr; 17(1):91. PubMed ID: 29678178
[TBL] [Abstract][Full Text] [Related]
10. NEDD4 expression is associated with breast cancer progression and is predictive of a poor prognosis.
Wan L; Liu T; Hong Z; Pan Y; Sizemore ST; Zhang J; Ma Z
Breast Cancer Res; 2019 Dec; 21(1):148. PubMed ID: 31856858
[TBL] [Abstract][Full Text] [Related]
11. Impact of pre-diagnostic triglycerides and HDL-cholesterol on breast cancer recurrence and survival by breast cancer subtypes.
Lofterød T; Mortensen ES; Nalwoga H; Wilsgaard T; Frydenberg H; Risberg T; Eggen AE; McTiernan A; Aziz S; Wist EA; Stensvold A; Reitan JB; Akslen LA; Thune I
BMC Cancer; 2018 Jun; 18(1):654. PubMed ID: 29902993
[TBL] [Abstract][Full Text] [Related]
12. Role of lipids, lipoproteins and vitamins in women with breast cancer.
Ray G; Husain SA
Clin Biochem; 2001 Feb; 34(1):71-6. PubMed ID: 11239519
[TBL] [Abstract][Full Text] [Related]
13. Glucose and lipoprotein biomarkers and breast cancer severity using data from the Swedish AMORIS cohort.
Melvin JC; Garmo H; Holmberg L; Hammar N; Walldius G; Jungner I; Lambe M; Van Hemelrijck M
BMC Cancer; 2017 Apr; 17(1):246. PubMed ID: 28376727
[TBL] [Abstract][Full Text] [Related]
14. Alterations of serum lipids and lipoproteins in breast cancer.
Kökoğlu E; Karaarslan I; Karaarslan HM; Baloğlu H
Cancer Lett; 1994 Jul; 82(2):175-8. PubMed ID: 8050088
[TBL] [Abstract][Full Text] [Related]
15. LDL-cholesterol signaling induces breast cancer proliferation and invasion.
dos Santos CR; Domingues G; Matias I; Matos J; Fonseca I; de Almeida JM; Dias S
Lipids Health Dis; 2014 Jan; 13():16. PubMed ID: 24428917
[TBL] [Abstract][Full Text] [Related]
16. [Effects of anastrozole on lipid metabolism in Chinese postmenopausal women with breast cancer].
Lu HH; Li Q; Xu BH; Zhang P; Yuan P; Wang JY; Cai RG
Zhonghua Zhong Liu Za Zhi; 2011 Jul; 33(7):520-5. PubMed ID: 22093630
[TBL] [Abstract][Full Text] [Related]
17. The effect of exemestane, anastrozole, and tamoxifen on lipid profiles in Japanese postmenopausal early breast cancer patients: final results of National Surgical Adjuvant Study BC 04, the TEAM Japan sub-study.
Hozumi Y; Suemasu K; Takei H; Aihara T; Takehara M; Saito T; Ohsumi S; Masuda N; Ohashi Y
Ann Oncol; 2011 Aug; 22(8):1777-82. PubMed ID: 21285133
[TBL] [Abstract][Full Text] [Related]
18. Prospective associations between serum biomarkers of lipid metabolism and overall, breast and prostate cancer risk.
His M; Zelek L; Deschasaux M; Pouchieu C; Kesse-Guyot E; Hercberg S; Galan P; Latino-Martel P; Blacher J; Touvier M
Eur J Epidemiol; 2014 Feb; 29(2):119-32. PubMed ID: 24519551
[TBL] [Abstract][Full Text] [Related]
19. Ki67 expression in breast cancer. Correlation with prognostic markers and clinicopathological parameters in Saudi patients.
Elkablawy MA; Albasri AM; Mohammed RA; Hussainy AS; Nouh MM; Alhujaily AS
Saudi Med J; 2016 Feb; 37(2):137-41. PubMed ID: 26837394
[TBL] [Abstract][Full Text] [Related]
20. Associations between serum lipids and breast cancer incidence and survival in the E3N prospective cohort study.
His M; Dartois L; Fagherazzi G; Boutten A; Dupré T; Mesrine S; Boutron-Ruault MC; Clavel-Chapelon F; Dossus L
Cancer Causes Control; 2017 Jan; 28(1):77-88. PubMed ID: 27864712
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
